|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 20 out of 20 for Nlrp3

Category restricted to InteractionExperiment (x)

0.028s

Categories

Category: InteractionExperiment
« show all
Type Details Score
Interaction Experiment
Xu T (2022)
Description: Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation.
•
•
•
•
•
Interaction Experiment
Lin Y (2022)
Description: TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.
•
•
•
•
•
Interaction Experiment
Qin Y (2021)
Description: TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation.
•
•
•
•
•
Interaction Experiment
Niu T (2021)
Description: NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly.
•
•
•
•
•
Interaction Experiment
Zhang L (2021)
Description: Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination.
•
•
•
•
•
Interaction Experiment
Duong BH (2015)
Description: A20 restricts ubiquitination of pro-interleukin-1 protein complexes and suppresses NLRP3 inflammasome activity.
•
•
•
•
•
Interaction Experiment
Song H (2016)
Description: The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3.
•
•
•
•
•
Interaction Experiment
Rao Z (2019)
Description: Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination.
•
•
•
•
•
Interaction Experiment
Tang J (2020)
Description: Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
•
•
•
•
•
Interaction Experiment
Magupalli VG (2020)
Description: HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation.
•
•
•
•
•
Interaction Experiment
Ren GM (2021)
Description: Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases.
•
•
•
•
•
Interaction Experiment
Wang D (2021)
Description: YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3.
•
•
•
•
•
Interaction Experiment
Cai B (2021)
Description: USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3.
•
•
•
•
•
Interaction Experiment
Panicker N (2022)
Description: Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinsons disease.
•
•
•
•
•
Interaction Experiment
Jiang F (2022)
Description: Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury.
•
•
•
•
•
Interaction Experiment
Li X (2017)
Description: MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism.
•
•
•
•
•
Interaction Experiment
Wu X (2022)
Description: Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity.
•
•
•
•
•
Interaction Experiment
Yang Z (2023)
Description: TREM-1 induces pyroptosis in cardiomyocytes by activating NLRP3 inflammasome through the SMC4/NEMO pathway.
•
•
•
•
•
Interaction Experiment
Kim JS (2023)
Description: Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3.
•
•
•
•
•
Interaction Experiment
Qin W (2021)
Description: Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on non-resolving inflammation via inhibition of NF-?B signaling and NLRP3 inflammasome activation.
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom